Latest news

Posts about investor

Michael Heltzen & Erum Azeez Khan

eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on Grow Everything podcast

Tyler Korman

Slack Capital interview: Tyler Korman, VP of Research

Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary update

Slack Capital: EXOZ investment report and CEO interview

eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today

eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST

eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health

AI transforming biotechnology: From form with AlphaFold to function with exozymes

Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper.

GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymes

Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman